Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesA first step to assess harm and benefit in clinical trials in one scale
Journal of Clinical Epidemiology, 10/08/09
Boers M et al. – A simple 3×3 table to rank both benefit and harm outcomes is feasible. For rheumatology this will be further developed in the context of the OMERACT initiative.
Related Articles
Increase in Quality, but Not Quantity, of Clinical Trials in Acute Pain: 1992 Versus 2007
Anesthesia & Analgesia, 10/21/09
Relevance Score: 69%
Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials
Cytokinetics, 11/10/09
Relevance Score: 68%
Methodological aspects of lung cancer clinical trials in the era of targeted agents
Lung Cancer, 11/03/09
Relevance Score: 68%
Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
Boston Scientific, 10/06/09
Relevance Score: 68%
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Cancer Chemotherapy and Pharmacology, 10/05/09
Relevance Score: 68%
Today in Epidemiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gender differences in patients with acute ischemic stroke
Women's Health, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09
Exercise-Induced Hypoxemia: Fact or Fallacy?
Medicine and Science in Sports and Exercise, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor